
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2026-07-31SGHC144Alinda Van Wyk plan to sell securities of Super Group (SGHC) Ltd under Form 144MEDIUM
Alinda Van Wyk filed Form 144 to notify SEC of plan to sell 23497 units of Super Group (SGHC) Ltd securities around 2026-07-31, with aggregate market value of $330,838.00. The total outstanding units is 508667619.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Mid CapGambling
2026-07-31GKOS144WEN LEANA plan to sell securities of GLAUKOS Corp under Form 144MEDIUM
WEN LEANA filed Form 144 to notify SEC of plan to sell 525 units of GLAUKOS Corp securities around 2026-07-31, with aggregate market value of $88,005.75. The total outstanding units is 58983937.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months include: On...
Mid CapMedical Devices
2026-07-31LTH144Weaver Erik plan to sell securities of Life Time Group Holdings, Inc. under Form 144MEDIUM
Weaver Erik filed Form 144 to notify SEC of plan to sell 47748 units of Life Time Group Holdings, Inc. securities around 2026-07-31, with aggregate market value of $2,139,110.40. The total outstanding units is 223461948.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in...
Mid CapLeisure
2026-07-31KMTS144Webster Brian Daniel plan to sell securities of KESTRA MEDICAL TECHNOLOGIES, LTD. under Form 144MEDIUM
Webster Brian Daniel filed Form 144 to notify SEC of plan to sell 8948 units of KESTRA MEDICAL TECHNOLOGIES, LTD. securities around 2026-07-31, with aggregate market value of $202,259.77. The total outstanding units is 58602497.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transac...
Small CapMedical Instruments & Supplies
2026-07-31DRI144LAURA WILLIAMSON plan to sell securities of DARDEN RESTAURANTS, INC. under Form 144MEDIUM
LAURA WILLIAMSON filed Form 144 to notify SEC of plan to sell 1110 units of DARDEN RESTAURANTS, INC. securities around 2026-07-31, with aggregate market value of $226,792.09. The total outstanding units is 114077969.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Mega CapRestaurants
2026-07-31DRI144CHRISTOPHER WILLIAMSON plan to sell securities of DARDEN RESTAURANTS, INC. under Form 144MEDIUM
CHRISTOPHER WILLIAMSON filed Form 144 to notify SEC of plan to sell 443 units of DARDEN RESTAURANTS, INC. securities around 2026-07-31, with aggregate market value of $90,768.31. The total outstanding units is 114077969.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Mega CapRestaurants
Sponsored
2026-07-31RCKY144Tracie Anne Winbigler plan to sell securities of Rocky Brands Inc. under Form 144MEDIUM
Tracie Anne Winbigler filed Form 144 to notify SEC of plan to sell 3000 units of Rocky Brands Inc. securities around 2026-07-31, with aggregate market value of $146,520.00. The total outstanding units is 7541363.0. The amount planned to be sold represents 0.04% of total outstanding units; ...
Small CapFootwear & Accessories
2026-07-31BDMD3Initial Statement of Beneficial OwnershipMEDIUM
This filing is an Initial Statement of Beneficial Ownership (Form 3) for Baird Medical Investment Holdings Ltd (BDMD). The reporting owner is ExcelFin SPAC LLC, which holds 4,249,031 ordinary shares directly. This ownership is further detailed through its managing members, Grand Fortune Capital, LLC (GFC) and ExcelFin ...
Nano CapMedical Devices
2026-07-31BGLC3Form 3 Filing for BioNexus Gene Lab Corp - Initial Statement of Beneficial OwnershipMEDIUM
This filing is an initial statement of beneficial ownership of securities (Form 3) for BioNexus Gene Lab Corp (BGLC). The reporting owner is Chong Set Fui, identified by CIK 0002076847. Fui Chong Set, the CFO of the company, has a direct ownership of the reported securities. The filing indicates that following the tran...
Nano CapSpecialty Chemicals
2026-07-31BGLC3Initial Statement of Beneficial Ownership of Securities
This filing reports the initial beneficial ownership of securities for Low Jook Yuen, a director at BioNexus Gene Lab Corp (BGLC). The filing indicates that following a transaction, Mr. Low Jook Yuen directly owns 1261 shares of the company's common stock. The report was filed on July 31, 2026, with the period of repor...
Nano CapSpecialty Chemicals
2026-07-31BGLC3Initial Statement of Beneficial Ownership
This filing reports that Yap Chee Keong, a director at BioNexus Gene Lab Corp, has initially acquired 0 shares of common stock. The ownership is direct, and the report was filed on March 7, 2022....
Nano CapSpecialty Chemicals
2026-07-31BGLC3Initial Statement of Beneficial Ownership of Securities
This filing reports the initial statement of beneficial ownership of securities for Tan Lee Su-Leng, CEO and Director of BioNexus Gene Lab Corp. The report, filed on August 15, 2023, indicates no securities owned following the transaction. The owner resides in Kuala Lumpur, Malaysia....
Nano CapSpecialty Chemicals
2026-07-31BioNexus Gene Lab Corp3Form 3 Filing for BioNexus Gene Lab Corp - Initial Statement of Beneficial OwnershipDuplicateMEDIUM
This filing is an initial statement of beneficial ownership of securities (Form 3) for BioNexus Gene Lab Corp (BGLC). The reporting owner is Chong Set Fui, identified by CIK 0002076847. Fui Chong Set, the CFO of the company, has a direct ownership of the reported securities. The filing indicates that following the tran...
Nano CapSpecialty Chemicals
Sponsored
2026-07-31SLRX3Form 3 Filing - Decoy Therapeutics Inc.
This filing is an initial report of beneficial ownership on Form 3 for Patricia G. Gauthier, a director at Decoy Therapeutics Inc. The filing indicates that no securities are beneficially owned by Ms. Gauthier as of the reporting date. The document also includes an exhibit which is a Power of Attorney. This Power of At...
Nano CapBiotechnology
2026-07-31Baird Medical Investment Holdings Ltd3Initial Statement of Beneficial OwnershipDuplicateMEDIUM
This filing is an Initial Statement of Beneficial Ownership (Form 3) for Baird Medical Investment Holdings Ltd (BDMD). The reporting owner is ExcelFin SPAC LLC, which holds 4,249,031 ordinary shares directly. This ownership is further detailed through its managing members, Grand Fortune Capital, LLC (GFC) and ExcelFin ...
Nano CapMedical Devices
2026-07-31GLRE3GREENLIGHT CAPITAL RE, LTD. - Form 3 Filing
This filing details a Form 3, Initial Statement of Beneficial Ownership, for GREENLIGHT CAPITAL RE, LTD. (GLRE). The reporting owner, Ariel Warszawski, who is a director at the company, reported 0 shares owned following the transaction. The ownership is direct. The filing date was July 31, 2026, with the period of repo...
Small CapInsurance - Reinsurance
2026-07-31Decoy Therapeutics Inc.3Form 3 Filing - Decoy Therapeutics Inc.Duplicate
This filing is an initial report of beneficial ownership on Form 3 for Patricia G. Gauthier, a director at Decoy Therapeutics Inc. The filing indicates that no securities are beneficially owned by Ms. Gauthier as of the reporting date. The document also includes an exhibit which is a Power of Attorney. This Power of At...
Nano CapBiotechnology
2026-07-31GEN3Power of Attorney for Travis WitteveenMEDIUM
This filing is an Exhibit 24, a Power of Attorney, for Travis Witteveen, Head of Products and Portfolio at Gen Digital Inc. The document, dated June 15, 2026, authorizes Bryan Ko, Whitney Clark, and Kathryn White to act as attorneys-in-fact. They are empowered to execute, deliver, and file Forms 3, 4, and 5, including ...
Large CapSoftware - Infrastructure
2026-07-31BioNexus Gene Lab Corp3Initial Statement of Beneficial Ownership of SecuritiesDuplicate
This filing reports the initial beneficial ownership of securities for Low Jook Yuen, a director at BioNexus Gene Lab Corp (BGLC). The filing indicates that following a transaction, Mr. Low Jook Yuen directly owns 1261 shares of the company's common stock. The report was filed on July 31, 2026, with the period of repor...
Nano CapSpecialty Chemicals
2026-07-31NSRX3Initial Statement of Beneficial Ownership of Securities
This filing reports the initial beneficial ownership of securities by Brendan P. O'Grady, Chief Executive Officer and Director of Nasus Pharma Ltd. (NSRX). The report is dated July 31, 2026, and pertains to the period ending July 27, 2026. Mr. O'Grady, residing in Tel-Aviv-Yafo, Israel, holds no securities directly as ...
Nano CapDrug Manufacturers - General
Sponsored
2026-07-31Nasus Pharma Ltd3Initial Statement of Beneficial Ownership of SecuritiesDuplicate
This filing reports the initial beneficial ownership of securities by Brendan P. O'Grady, Chief Executive Officer and Director of Nasus Pharma Ltd. (NSRX). The report is dated July 31, 2026, and pertains to the period ending July 27, 2026. Mr. O'Grady, residing in Tel-Aviv-Yafo, Israel, holds no securities directly as ...
Nano CapDrug Manufacturers - General
2026-07-31PAY3Power of Attorney for Gregory Hyde WilliamsMEDIUM
This filing details a Limited Power of Attorney granted by Gregory Hyde Williams, a director at Paymentus Holdings, Inc. (PAY), to Thomas C. Barnds. This appointment authorizes Barnds to act on Williams' behalf regarding securities transactions and filings with the SEC. This includes executing necessary forms such as S...
Mid CapSoftware - Infrastructure
2026-07-31TOP3Form 3 Filing for TOP Financial Group LtdHIGH
This filing details insider ownership for TOP Financial Group Ltd. Yang Junli, identified as a 10% owner, officer, and director, reports holdings through two entities: Zhong Yang Holdings (BVI) Limited and QUANTUM LEAP LIMITED. Yang Junli holds 10,000,000 Class B Ordinary Shares directly. Indirectly, through Zhong Yang...
Small CapCapital Markets
2026-07-31TOP3Insider Filing for TOP Financial Group Ltd
This filing reports insider ownership information for TOP Financial Group Ltd. The reporting owner, Yuen Ka Fai, who is a Director & CEO of the company, has reported no securities owned as of March 18, 2026. The signature date was July 31, 2026. This is a Form 3 filing, which is an initial statement of beneficial owner...
Small CapCapital Markets